This invention provides compounds defined by Formula (I) or a pharmaceutically acceptable salt thereof, wherein R?l, Q, Yl, Y2, Y3Y, R2a, R2b, R5¿, and n are as defined in the specification. The invention also provides pharmaceutical compositions comprising a compound of Formula (I) and the use of the compounds of Formula (I) as matrix metalloproteinase inhibitors.
本发明提供了公式(I)或其药学上可接受的盐所定义的化合物,其中R?l,Q,Yl,Y2,Y3Y,R2a,R2b,R5¿和n如规范中所定义。本发明还提供了包含公式(I)化合物的制药组合物,并且提供了将公式(I)化合物用作基质
金属蛋白酶抑制剂的用途。